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Background
Survivin and XIAP inhibitor of apoptosis proteins (IAPs)
and FoxM1 transcription factor overexpression are asso-
ciated with poor prognosis in breast cancer. This work
aimed at investigating the role of these proteins in doxoru-
bicin (dox) resistance in breast cancer cells.
Materials and methods
Human breast carcinoma cell lines MCF7 (wild-type p53)
and MDA-MB-231 (mutant p53) were exposed to dox and
citotoxicity was assessed through the MTT assay. Apopto-
sis was detected through analysis of flow cytometry DNA
content and caspases-3, -7 and -9 levels. Survivin, XIAP,
p53 and FoxM1 levels were assessed by Western blotting
and Survivin and XIAP mRNA levels, by Real Time PCR.
Transfections with the Survivin-encoding plasmid and
siRNA against Survivin and XIAP were performed using
Lipofectamine reagent.
Results
Dox induced DNA fragmentation and reduction in procas-
pases-3, -7 and -9 levels in both cells, independently of
their p53 status. Upon dox-mediated apoptosis, Survivin
and XIAP levels were reduced. Survivin-induced overex-
pression did not confer cells a dox resistant-phenotype
and Survivin silencing, alone or in combination with
XIAP, did not result in enhanced sensitivity to the drug.
Furthermore, Survivin and XIAP mRNA levels were
downregulated after dox treatment, concurrently with
FoxM1 transcription factor inhibition.
Conclusion(s)
Our data show that Survivin and XIAP downregulation
are not crucial events in dox-induced apoptosis and sug-
gest that their regulation might be a consequence of
FoxM1 transcription factor inhibition. It still remains to
be investigated whether FoxM1 modulation directly
affects IAPs expression and cell sensitivity to dox-
mediated apoptosis.
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